Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Sodium N-acetylneuraminate
RN: 92413-99-5
UNII: C4WSL8GQZ2
InChIKey: QKFTYFYIYXTFBX-BKSOAOGQSA-M

Classification Code

  • Drug / Therapeutic Agent

Molecular Formulas

  • C11-H18-N-O9.Na
  • C11-H19-N-O9.Na

Molecular Weight

  • 331.2512
 
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Other Resources (Internet Locators)


Search for this InChIKey on the Web

Names and Synonyms

Results Name

  • Sodium N-acetylneuraminate

Name of Substance

  • Sodium aceneuramate

Synonyms

  • 5-(Acetylamino)-3,5-dideoxy-D-glycero-D-galacto-2-nonulosonic acid monosodium salt
  • KI-111
  • KI-III
  • Sodium 5-(acetylamino)-3,5-dideoxy-D-glycero-D-galacto-2-nonulosonate
  • Sodium N-acetylneuraminate
  • UNII-C4WSL8GQZ2

Systematic Name

  • D-glycero-beta-D-galacto-2-Nonulopyranosonic acid, 5-(acetylamino)-3,5-dideoxy-, monosodium

Registry Numbers

CAS Registry Number

  • 92413-99-5

FDA UNII

  • C4WSL8GQZ2

System Generated Number

  • 0092413995

Molecular Formulas

Molecular Formulas

  • C11-H18-N-O9.Na
  • C11-H19-N-O9.Na

Molecular Formula Fragments

  • C11-H18-N-O9
  • C11-H19-N-O9
  • COMPONENT
  • Na

Structure Descriptors

InChI

1S/C11H19NO9.Na/c1-4(14)12-7-5(15)2-11(20,10(18)19)21-9(7)8(17)6(16)3-13;/h5-9,13,15-17,20H,2-3H2,1H3,(H,12,14)(H,18,19);/q;+1/p-1/t5-,6+,7+,8+,9+,11-;/m0./s1

InChIKey

QKFTYFYIYXTFBX-BKSOAOGQSA-M

Smiles

[Na+].CC(=O)N[C@@H]1[C@@H](O)C[C@](O)(O[C@H]1[C@H](O)[C@H](O)CO)C(=O)[O-]

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LD50 intravenous > 5gm/kg (5000mg/kg) GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE
European Patent Application. Vol. #386657,
guinea pig LD50 intravenous > 5gm/kg (5000mg/kg) KIDNEY, URETER, AND BLADDER: INCONTINENCE

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
European Patent Application. Vol. #386657,
mouse LD50 intraperitoneal > 5gm/kg (5000mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

KIDNEY, URETER, AND BLADDER: INCONTINENCE
European Patent Application. Vol. #386657,
mouse LD50 intravenous > 5gm/kg (5000mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

KIDNEY, URETER, AND BLADDER: INCONTINENCE
European Patent Application. Vol. #386657,
mouse LD50 oral > 5gm/kg (5000mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

KIDNEY, URETER, AND BLADDER: INCONTINENCE
European Patent Application. Vol. #386657,
mouse LD50 subcutaneous > 5gm/kg (5000mg/kg) KIDNEY, URETER, AND BLADDER: INCONTINENCE

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
European Patent Application. Vol. #386657,
rat LC50 inhalation > 4gm/m3 (4000mg/m3)   Kiso to Rinsho. Clinical Report. Vol. 21, Pg. 2564, 1987.
rat LD50 intraperitoneal > 5gm/kg (5000mg/kg) KIDNEY, URETER, AND BLADDER: INCONTINENCE

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
European Patent Application. Vol. #386657,
rat LD50 intravenous > 5gm/kg (5000mg/kg) KIDNEY, URETER, AND BLADDER: INCONTINENCE

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
European Patent Application. Vol. #386657,
rat LD50 oral > 5gm/kg (5000mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

KIDNEY, URETER, AND BLADDER: INCONTINENCE
European Patent Application. Vol. #386657,
rat LD50 subcutaneous > 5gm/kg (5000mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

KIDNEY, URETER, AND BLADDER: INCONTINENCE
European Patent Application. Vol. #386657,